| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $75.54 | $17.66 | 327.74% | 314.75x | 22.12x | 23.08x | 61.87x | 1.55x | $41.15M | 0.62% | $108.58M | 1.23 | $6.68B | 124.63 | ||
| CORT | CORCEPT THERAPEUTICS INC | $81.56 | $20.75 | 293.07% | 177.30x | 155.77x | 11.08x | 13.72x | 1.50x | $119.79M | 1.41% | $637.99M | 6.11 | $8.66B | -1,260.78 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $7.40 | $2.92 | 153.00% | 105.71x | 69.09x | 4.01x | 98.19x | 0.97x | $47.52M | 3.77% | $13.01M | 0.08 | $1.42B | 26.66 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $294.06 | $93.53 | 214.42% | 67.44x | 38.99x | 9.12x | 36.51x | 1.40x | $641.34M | 1.64% | $1.08B | 8.09 | $40.52B | 43.83 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $59.13 | $17.32 | 241.34% | 60.34x | 46.31x | 6.00x | 7.51x | 1.63x | $164.23M | 3.63% | $605.69M | 7.92 | $4.37B | 39.18 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.15 | $71.35 | -0.27% | 24.04x | 8.58x | 5.57x | 38.42x | 0.43x | $667.65M | 7.94% | $219.64M | 1.86 | $10.27B | 16.47 | ||
| KRYS | KRYSTAL BIOTECH INC | $347.63 | $95.39 | 264.42% | 44.86x | 43.72x | 24.40x | 8.03x | 2.14x | $237.38M | 2.33% | $1.28B | 43.59 | $9.76B | 45.60 | ||
| ADMA | ADMA BIOLOGICS INC | $8.70 | $9.69 | -10.21% | 12.61x | 9.51x | 4.03x | 5.17x | 0.48x | $107.90M | 5.25% | $390.33M | 1.65 | $2.08B | 9.37 | ||
| VCEL | VERICEL CORP | $41.69 | $9.14 | 356.27% | 96.95x | 86.48x | 7.25x | 5.98x | 2.04x | $47.49M | 2.24% | $356.23M | 7.02 | $2.11B | 52.31 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $13.08 | $15.97 | -18.09% | 6.38x | 27.28x | 6.25x | 3.76x | 0.85x | $56.42M | 7.39% | $205.80M | 3.52 | $678.78M | 4.69 | ||
| RPRX | ROYALTY PHARMA PLC | $54.28 | $39.89 | 36.09% | 28.42x | 10.18x | 9.72x | 3.15x | 0.61x | $2.34B | 9.87% | $9.94B | 22.75 | $39.63B | 34.06 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.33 | $41.78 | 37.21% | 40.95x | 15.12x | 3.40x | 1.78x | 0.56x | $767.06M | 6.95% | $6.21B | 32.27 | $9.44B | 19.56 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $229.85 | $49.41 | 365.23% | 489.04x | 8.93x | 3.21x | 3.18x | 1.65x | $1.30B | 9.12% | $4.53B | 73.22 | $17.98B | 26.63 | ||
| ASND | ASCENDIS PHARMA A | $238.01 | $80.70 | 194.93% | 25.23x | 15.96x | 14.51x | 25.75x | 2.58x | $52.94M | 0.36% | $574.09M | 9.24 | $15.16B | 162.61 | ||
| TGTX | TG THERAPEUTICS INC | $53.60 | $17.04 | 214.63% | 16.65x | 38.32x | 11.05x | 14.07x | 263.77x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.51B | 56.75 | ||
| TECH | BIO-TECHNE CORP | $58.88 | $15.32 | 284.30% | 82.92x | 30.01x | 7.60x | 4.42x | 1.71x | $269.60M | 2.93% | $2.09B | 13.34 | $9.30B | 36.33 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.45 | $35.75 | -3.64% | 13.62x | 9.36x | 2.22x | 2.19x | 0.52x | $341.79M | 17.16% | $910.35M | 15.75 | $1.56B | 6.60 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $284.91 | $94.39 | 201.84% | 36.06x | 31.39x | 20.64x | 5.73x | 1.81x | $122.22M | 2.16% | $997.32M | 50.16 | $6.05B | 26.81 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.10 | $5.74 | -63.39% | 7.78x | 3.07x | 1.97x | 2.30x | 0.16x | $7.24M | 6.00% | $52.93M | 0.92 | $67.94M | 4.38 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $475.20 | $167.94 | 182.96% | 27.94x | 24.31x | 9.88x | 6.23x | 2.04x | $3.71B | 3.07% | $19.36B | 76.20 | $117.10B | 21.71 | ||
| EXEL | EXELIXIS INC | $52.87 | $30.85 | 71.40% | 16.95x | 16.05x | 5.75x | 6.87x | 1.23x | $917.69M | 6.72% | $1.94B | 7.49 | $13.23B | 12.53 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.42 | $12.25 | 156.53% | 17.36x | 16.02x | 6.43x | 3.80x | 3.90x | $208.13M | 5.42% | $1.01B | 8.28 | $3.09B | 9.23 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.45 | $2.46 | 40.26% | 14.38x | 14.58x | 2.11x | 3.34x | 0.97x | $4.11M | 1.48% | $82.33M | 1.03 | $210.80M | 9.92 | ||
| UTHR | UNITED THERAPEUTICS CORP | $549.90 | $243.25 | 126.06% | 18.78x | 19.33x | 7.55x | 3.96x | 2.08x | $1.02B | 4.25% | $5.90B | 135.66 | $22.06B | 12.88 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $623.43 | $436.01 | 42.99% | 14.65x | 13.25x | 4.35x | 2.08x | 0.99x | $4.11B | 6.34% | $31.42B | 302.15 | $65.10B | 11.33 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.24 | $1.26 | 77.74% | 11.79x | 10.31x | 2.34x | 2.68x | 2.91x | $13.00M | 7.28% | $67.23M | 0.84 | $147.25M | 6.60 | ||
| INCY | INCYTE CORP | $108.46 | $66.86 | 62.21% | 14.88x | 13.85x | 4.03x | 3.85x | 1.28x | $1.45B | 6.71% | $5.62B | 28.21 | $18.24B | 9.75 | ||
| VCYT | VERACYTE INC | $56.76 | $7.60 | 646.79% | 51.14x | 50.90x | 8.33x | 3.37x | 10.89x | $155.34M | 3.44% | $1.34B | 16.90 | $4.30B | 37.41 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $16.70 | $3.61 | 362.82% | 27.83x | 4.56x | 0.80x | 1.17x | 12.59x | $109.24M | 6.23% | $1.51B | 14.34 | $2.33B | 28.22 | ||
| MDXG | MIMEDX GROUP INC | $3.83 | $1.25 | 205.18% | 18.24x | -45.49x | 1.46x | 2.35x | 8.67x | $69.36M | 12.19% | $242.94M | 1.64 | $428.28M | 7.86 |